DMD treatment SAT-3247 was safe and well-tolerated, and showed signs of increasing muscle strength in five adults, Satellos ...

Satellos said that it will be advancing its DMD small molecule to a Phase II trial, following the Phase I data.

We're very fortunate where I work in Philadelphia to have a robust pediatric team and also a robust adult-focused care team for muscular dystrophy. And so our ability to have this transition ...

The study focused on adults, a demographic representing individuals ... to regenerate skeletal muscle that is lost in Duchenne muscular dystrophy and other degenerative or injury conditions.

Columnist Patrick Moeschen shares how he's learned to turn the physical weakness of muscular dystrophy into a strength.

A Co Down woman is encouraging people living with a muscle wasting or weakening condition, their families and carers to join ...

A rare and fatal form of muscular dystrophy has long posed a devastating diagnosis for children, primarily affecting boys.

Two children and 1 adult with neurogenic weakness were also ... Opinions concerning the desirability of active and resistive exercise in muscular dystrophy are also conflicting.

Participating partners include, Alaska Commercial Company, Albertsons Companies Foundation, American Furniture Warehouse, ...

The Information Day takes place on Wednesday 4 June 2025, in Lisburn, Co. Antrim, and is organised by Muscular Dystrophy UK, the leading charity for more than ...

Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) ("Satellos" or the "Company"), a biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and ...